Jul 13, 2026 03:27PM
Jun 18, 2026 04:58PM
Jun 18, 2026 04:56PM
Jun 10, 2026 12:03PM
Jun 10, 2026 12:03PM
Jun 5, 2026 11:30AM
May 21, 2026 01:24PM EMA accepts Teva application for long-acting olanzapine schizophrenia drug
May 21, 2026 01:24PM
May 6, 2026 08:58AM
Apr 29, 2026 07:39AM
Apr 29, 2026 06:30AM
Apr 29, 2026 06:30AM
Mar 9, 2026 10:53AM
Feb 20, 2026 03:38PM FDA accepts Teva's drug application for monthly schizophrenia treatment
Feb 20, 2026 03:37PM
Feb 20, 2026 02:43PM
Feb 20, 2026 02:43PM
Feb 19, 2026 04:00PM
Jan 28, 2026 05:05PM
Jan 23, 2026 10:09AM
Jan 14, 2026 05:03PM Teva's AJOVY reduces migraine days in children in clinical trial
Jan 14, 2026 05:02PM
Jan 12, 2026 04:07AM
Jan 12, 2026 04:04AM
Dec 22, 2025 07:06AM
Dec 19, 2025 03:30AM
Dec 12, 2025 10:47AM
Dec 9, 2025 08:02AM Teva submits FDA application for monthly schizophrenia injection
Dec 9, 2025 08:00AM
Nov 5, 2025 07:00AM
Oct 24, 2025 08:29AM
Oct 10, 2025 04:11PM
Oct 10, 2025 04:11PM
Oct 10, 2025 03:00PM
Oct 10, 2025 03:00PM FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
Sep 23, 2025 12:52AM
Sep 17, 2025 08:01AM
Jul 30, 2025 07:00AM
Jun 18, 2025 08:45AM
May 29, 2025 08:07AM
May 5, 2025 07:03AM
Apr 7, 2025 07:31AM Teva Pharma (TEVA) Announces FDA Filing Acceptance for AJOVY in Pediatric Episodic Migraine Prevention
Apr 7, 2025 07:30AM
Feb 25, 2025 05:03PM
Feb 25, 2025 04:29PM
Feb 21, 2025 06:26AM
Jan 27, 2025 06:02AM
Jan 8, 2025 12:31PM
Nov 1, 2024 03:00PM Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (o
Oct 22, 2024 09:22AM

325,445 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All